Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Average Return on Assets (ROA)

Return on Assets (ROA)

The current return on assets (roa) for Intuitive Surgical, Inc. (ISRG) is 13.84% as of Wednesday, June 10, 2026, shown against its trailing averages.

Average Return on Assets (ROA) Chart

ISRG Return on Assets (ROA) Averages

RETURN ON ASSETS (ROA) CURRENT

13.84%

RETURN ON ASSETS (ROA) TTM

13.09%

RETURN ON ASSETS (ROA) 3Y

12.00%

RETURN ON ASSETS (ROA) 5Y

11.68%

RETURN ON ASSETS (ROA) 10Y

12.13%

RETURN ON ASSETS (ROA) 15Y

13.08%

RETURN ON ASSETS (ROA) 20Y

13.30%

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa